We're interrupting our regular editorial calendar to bring you a special article Clinical Trials in Central and Eastern Europe, written by Language Connections' Director of Biotech and Pharmaceutical Research, Karen Politis Virk, MS. 
 
With access to the Language Connections global pharmaceutical and biotech client base, and through independent scholarly research, Karen has distilled the essentials of incorporating language and culture into critical clinical work in this fast-growing region of the world.
 
Since 2000, the number of clinical trials in Central and Eastern Europe (CEE) increased by 12% per year, compared to 8% worldwide; in Russia alone, the growth rate reached an impressive 18%.  Successful companies operating in CEE countries know first-hand that language fluency and cultural sensitivity are paramount to everything they do. 
 
Whether you are firmly entrenched in the market or contemplating entry into CEE, we invite you to be among the first to read this important new article.  The Association of Clinical Trials Professionals (ACRP) will publish Karen's article in its October issue of the ACRP Monitor.  But, with permission from the Monitor's editor, we wanted to give our community a first look. 
 
Please access the article here Clinical Trials in Central and Eastern Europe: The Challenge of Dealing with Multiple Languages and Cultures , and as always, feel free to give us a call with any comments or questions.  We always enjoy hearing from you.  In October, we'll be writing you about the race for biotech in Asia, an exciting story with huge implications for the growth of biotech research and manufacturing in China.
 
Until then, best regards,